About
Technology
Issues
FAQ
Links
Official Page
Significantly Longer Progression-Free Survival With
nab
-Paclitaxel Compared With Docetaxel As First-Line Therapy for Metastatic Breast Cancer
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.